KAI Pharmaceuticals Director of Business Development Salaries in Baltimore, MD
The average KAI Pharmaceuticals Director of Business Development in Baltimore, MD earns an estimated $177,967 annually, which includes an estimated base salary of $126,342 with a $51,625 bonus. KAI Pharmaceuticals' Director of Business Development compensation is $11,701 more than the US average for a Director of Business Development. Director of Business Development salaries at KAI Pharmaceuticals in Baltimore, MD can range from $83,500 - $248,000.
In Baltimore, MD, The Business Development Department at KAI Pharmaceuticals earns $9,915 more on average than the Finance Department.
Last updated 5 years ago.
- $126,342
- avg. base
- $51,625
- avg. bonus
Director of Business Development Salaries at KAI Pharmaceuticals
In Baltimore, MD, Directors of Business Development earn $398 more than Directors of Business Development.
Compensation at KAI Pharmaceuticals by Department
In Baltimore, MD, The Business Development Department averages $9,915 more than the Finance Department, and $8,967 less than the IT Department
Director of Business Development Compensation by Gender (All Companies)
The average female Director of Business Development at companies similar size to KAI Pharmaceuticals reported making $205,320, while the average male Director of Business Development at similar sized companies reported making $214,912.
Director of Business Development Compensation by Ethnicity (All Companies)
The average African American/Black Director of Business Development at companies similar size to KAI Pharmaceuticals reported making $217,667, while the average Hispanic or Latino Director of Business Development at similar sized companies reported making $185,667.
How Directors of Business Development at KAI Pharmaceuticals Rate Their Compensation
The majority of Directors of Business Development at KAI Pharmaceuticals believe they're compensated fairly. 100% of Directors of Business Development at KAI Pharmaceuticals say they receive annual bonuses, and the majority (50%) are satisfied with their benefits. See more compensation ratings at KAI Pharmaceuticals
